Periodic alternating interface positioning to lower WBC contamination of apheresis platelet concentrates: A multicenter evaluation

Transfusion

Volumn 40, Issue 6, 2000, Pages 687-692

  Zeiler, Thomas ^a   Zingsem, J ^b   Moog, R ^b   Kretschmer, V ^b   Eckstein, R ^b   Muller N ^b   Eisenbeisz, F ^b  

^a UNIVERSITY HOSPITAL MARBURG   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL SELECTION; CELL SEPARATION; CELL SORTER; CLINICAL TRIAL; COMPUTER PROGRAM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; LEUKOCYTE; MULTICENTER STUDY; THROMBOCYTOPHERESIS;

BLOOD PLATELETS; CENTRIFUGATION; EVALUATION STUDIES; HUMANS; LEUKOCYTE COUNT; LEUKOCYTES; PLATELETPHERESIS; QUALITY CONTROL; SOFTWARE;

EID: 0034044720     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2000.40060687.x     Document Type: Article

References (30)

1. Murphy MF. Clinical aspects of platelet transfusion therapy. Infusionsther Transfusionsmed 1994;21(Suppl 3):34-8.
2. Brand A, Claas FH, Voogt PJ, et al. Alloimmunization after leukocyte-depleted multiple random donor platelet transfusions. Vox Sang 1988;54:160-6.
3. Murphy MF, Waters AH. Platelet transfusions: the problem of refractoriness. Blood Rev 1990;4:16-24.
4. Lane TA, Anderson KC, Goodnough LT, et al. Leukocyte reduction in blood component therapy. Ann Intern Med 1992;117:151-62.
5. Reesink HW, Nydegger UE, Brand A, et al. Should all platelet concentrates issued be leukocyte-poor? Vox Sang 1992;62:57-64.
6. Fisher M, Chapman JR, Ting A. Morris PJ. Alloimmunisation to HLA antigens following transfusion with leucocytepoor and purified platelet suspensions. Vox Sang 1985;49:331-5.
7. Saarinen UM, Kekomaki R, Siimes MA, Myllyla G. Effective prophylaxis against platelet refractoriness in multitransfused patients by use of leukocyte-free blood components. Blood 1990;75:512-7.
8. Heddle NM. The efficacy of leukodepletion to improve platelet transfusion response: a critical appraisal of clinical studies. Transfus Med Rev 1994;8:15-28.
9. Klein H, ed. Standards for blood banks and transfusion services. 16th ed. Bethesda: American Association of Blood Banks, 1994.
10. [Regulations for determinations of blood groups and blood transfusion (hemotherapy). Scietific Advisory Board of the Bundesärztekammer and the Paul-Erlich Institute.] Köln: Deutscher Ärzte Verlag, 1996.
11. Gilben GL, Hayes K, Hudson IL, lames J. Prevention of transfusion-acquired cytomegalovirus infection in infants by blood filtration to remove leucocytes. Neonatal Cytomegalovirus Infection Study Group. Lancet 1989;1:1228-31.
12. Bowden RA, Slichter SJ, Sayers M, et al. A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant. Blood 1995;86:3598-603.
13. De Witte T, Schattenberg A, Van Dijk BA, et al. Prevention of primary cytomegalovirus infection after allogeneic bone marrow transplantation by using leukocyte-poor random blood products from cytomegalovirus-unscreened blood-bank donors. Transplantation 1990;50:964-8.
14. Muylle L, Joos M, Wouters E, De Bock R, Peeterrnans ME. Increased tumor necrosis factor α (TNFα), interleukin 1, and interleukin 6 (IL-6) levels in the plasma of stored platelet concentrates: relationship between TNFα and IL-6 levels and febrile transfusion reactions. Transfusion 1993;33:195-9.
15. Aye MT, Palmer DS, Giulivi A, Hashemi S. Effect of filtration of platelet concentrates on the accumulation of cytokines and platelet release factors during storage. Transfusion 1995;35:117-24.
16. Muylle L, Wouters E, Peeterrnans ME. Febrile reactions to platelet transfusion: the effect of increased interleukin 6 levels in concentrates prepared by the platelet-rich plasma method. Transfusion 1996;36:886-90.
17. Kao KJ, Mickel M, Braine HG, et al. White cell reduction in platelet concentrates and packed red cells by filtration: a multicenter clinical trial. The Trap Study Group. Transfusion 1995;35:13-9.
18. Moog R, Muller N, Kobke AC, Kalb R. Leukocyte filtration of single-donor platelet units through an integrated filter system for the Fresenius AS 104 blood cell separator. Vox Sang 1997:72:107-10.
19. Weisbach V, Riess H, Gindi N, et al. [Effect of leukocyte depleting polyester filters on thrombocytapheresis concentrates] (Engl abstract). Beitr lnfusionsther 1992;30:170-3.
20. Fournel JJ, Zingsem J, Riggert J, et al. A multicenter evaluation of the routine use of a new white cell-reduction apheresis system for collection of platelets. Transfusion 1997;37:487-92.
21. Yockey C, Murphy S, Eggers I, et al. Evaluation of the Amicus Separator in the collection of apheresis platelets. Transfusion 1998;38:848-54.
22. Moog R, Valbonesi M, Cartier P, et al. Collection of platelets and peripheral progenitor cells with the Fresenius AS.TEC 204 Blood Cell Separator. J Clin Apheresis 1997;12:126-9.
23. Zingsem J, Zimmermann R, Weisbach V, et al. Comparison of COBE white cell-reduction and standard plateletpheresis protocols in the same donors. Transfusion 1997:37:1045-9.
24. Dumont LJ, Dzik WH, Rebulla P, Brandwein H. Practical guidelines for process validation and process control of white cell-reduced blood components: report of the Biomedical Excellence for Safer Transfusion (BEST) Working Party of the International Society of Blood Transfusion (ISBT). Transfusion 1996;36:11-20.
25. Muller N, Kretschmer V, Godehardt E, et al. Improvement of separation efficiency and concentrate purity of the Fresenius cell separator AS 104: results of a multicenter study. Haemapheresis Scientific Workshop Group of DGTI. Transfus Sci 1993;14:105-14.
26. Zeiler T, Kretschmer V. In-line leukocyte depletion of thrombocytapheresis concentrates with the Fresenius-AS-104 cell separator. Infusionsther Transfusionsmed 1997;34:110-3.
27. Guide to the preparation, use and quality assurance of blood components. 3rd ed. Strasbourg: Council of Europe Publishing, 1997.
28. Sweeney JD, Holme S, Stromberg RR, Heaton WA. In vitro and in vivo effects of prestorage filtration of apheresis platelets. Transfusion 1995;35:125-30.
29. Moog R, Muller N. Evaluation of the single needle procedure in plateletpheresis with the fresenius AS 104 blood cell separator. J Clin Apheresis. 1995;10:90-5.
30. Zeiler T, Schulzki T, Wilbert U, Kretschmer U. In vitro evaluation of platelet concentrates with respect to preparation technique and storage time, Infusionsther Transfusionsmed 1995;22(Suppl 2):54.